Work

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders

Year: 2026

Type: article

Source: Thrombosis and Haemostasis

DOI: 10.1055/a-2894-0856

Authors: Claire Auditeau, Elsa P. Bianchini, Ivan Peyron, Andréa Ruty, Pradtahna Saenjamsai, Mariem Khamari, Tilman M. Hackeng, Olivier D. Christophe, Cecile V. Denis, Delphine Borgel, Peter J. Lenting, FranÇois Saller

Institutions: Hôpital Necker-Enfants Malades, Inserm, Université Paris-Saclay, Assistance Publique – Hôpitaux de Paris, Inovarion (France), Maastricht University, Centre Hospitalier Régional et Universitaire de Nancy

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W7166701260

FWCI:

Cites: 37

Cited by:

Related to: